Combined BRM270 and endostatin inhibit relapse of NSCLC while suppressing lung cancer stem cell proliferation induced by endostatin

Endostatin (ES, ENDO) has been reported to suppress the growth of tumors while inducing the proliferation of lung cancer stem cells (LCSCs), causing a poor prognosis for lung cancer. In this study, we aimed to clarify whether BRM270 can inhibit the proliferation of cancer stem cells (CSCs). Endostat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Yan-hui, Shen, Yong-chun, Ou-yang, Yao, Rao, Xi-min, Fu, Dan-dan, Wen, Fu-qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433059/
https://www.ncbi.nlm.nih.gov/pubmed/34553041
http://dx.doi.org/10.1016/j.omto.2021.05.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433059/
https://www.ncbi.nlm.nih.gov/pubmed/34553041
http://dx.doi.org/10.1016/j.omto.2021.05.011

Ejemplares similares